CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GPC Biotech AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GPC Biotech AG
Fraunhoferstrasse 20
Phone: (89) 856-52600p:89 856-52600 Martinsried/Munich, 82152  Germany Ticker: GPC GPC

This company is no longer actively traded on any major stock exchange.

Business Summary
GPC Biotech AG is a biopharmaceutical company, which is engaged in the research, development and commercialization of anticancer drugs. Its lead product candidate is satraplatin, a platinum-based compound intended for use as a chemotherapy treatment. The Company has two programs in clinical development: satraplatin, an oral platinum compound and RGB-286638, a multi-targeted protein kinase inhibitor. GPC Biotech AG operates through one wholly owned subsidiary headquartered in Princeton, New Jersey, the United States.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/200912/31/2008Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Supervisory Board JuergenDrews 6/5/2001 1/1/1998
Member of the Management Board, Interim Chief Executive Officer FriedrichVon Bohlen und Halbach 47 6/30/2009 6/30/2009
Member of the Management Board, Chief Financial Officer, Senior Vice President TorstenHombeck 39 1/1/2008
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 45 (As of 6/30/2009)
Outstanding Shares: 36,836,853 (As of 6/30/2009)
Shareholders: 4,583
Stock Exchange: ETR
Fax Number: (89) 856-52610


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023